health partners glp 1 coverage GLP-1 in Employer Plans Could Nearly Double in 2024 Massachusetts cuts GLP-1 coverage for

In addition, the FDA has updated Ozempics label to include warnings about gastrointestinal obstruction and delayed gastric emptying (gastroparesis)

The most common reasons for stopping included: Millennials were the quickest to do so (about 3 months, on average), while baby boomers tended to stay on longest (about 5 months)

Form Founded: 2019 Total funding: $27 million What Form does: Form, based in Boston, works with employers to offer its weight-loss program to workers as an employee benefit

Many GLP-1 weight loss medications are considered for adults with obesity or adults with overweight and at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes risk, or similar metabolic concerns

But its not clear whether these benefits are from the drug or the weight loss